PNC Financial Services Group’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-60,280
| Closed | -$120K | – | 4185 |
|
|
2019
Q3 | $120K | Hold |
60,280
| – | – | ﹤0.01% | 2440 |
|
|
2019
Q2 | $130K | Buy |
60,280
+3,400
| +6% | +$7.33K | ﹤0.01% | 2413 |
|
|
2019
Q1 | $180K | Buy |
56,880
+940
| +2% | +$2.98K | ﹤0.01% | 2205 |
|
|
2018
Q4 | $140K | Buy |
55,940
+1,280
| +2% | +$3.2K | ﹤0.01% | 2270 |
|
|
2018
Q3 | $220K | Sell |
54,660
-1,100
| -2% | -$4.43K | ﹤0.01% | 2142 |
|
|
2018
Q2 | $210K | Buy |
55,760
+4,560
| +9% | +$17.2K | ﹤0.01% | 2155 |
|
|
2018
Q1 | $118K | Sell |
51,200
-200
| -0.4% | -$461 | ﹤0.01% | 2469 |
|
|
2017
Q4 | $80K | Hold |
51,400
| – | – | ﹤0.01% | 2684 |
|
|
2017
Q3 | $110K | Hold |
51,400
| – | – | ﹤0.01% | 2477 |
|
|
2017
Q2 | $232K | Sell |
51,400
-1,600
| -3% | -$7.22K | ﹤0.01% | 2053 |
|
|
2017
Q1 | $160K | Hold |
53,000
| – | – | ﹤0.01% | 2242 |
|
|
2016
Q4 | $146K | Hold |
53,000
| – | – | ﹤0.01% | 2271 |
|
|
2016
Q3 | $166K | Buy |
53,000
+17,420
| +49% | +$54.6K | ﹤0.01% | 2193 |
|
|
2016
Q2 | $182K | Hold |
35,580
| – | – | ﹤0.01% | 2156 |
|
|
2016
Q1 | $146K | Buy |
35,580
+740
| +2% | +$3.04K | ﹤0.01% | 2299 |
|
|
2015
Q4 | $282K | Buy |
34,840
+5,480
| +19% | +$44.4K | ﹤0.01% | 1867 |
|
|
2015
Q3 | $248K | Buy |
29,360
+2,940
| +11% | +$24.8K | ﹤0.01% | 1993 |
|
|
2015
Q2 | $248K | Buy |
26,420
+7,360
| +39% | +$69.1K | ﹤0.01% | 2079 |
|
|
2015
Q1 | $176K | Buy |
19,060
+6,940
| +57% | +$64.1K | ﹤0.01% | 2328 |
|
|
2014
Q4 | $112K | Buy |
12,120
+7,380
| +156% | +$68.2K | ﹤0.01% | 2412 |
|
|
2014
Q3 | $42K | Buy |
+4,740
| New | +$42K | ﹤0.01% | 2763 |
|